Exercise Training After Lung Transplantation
Does supervised exercise following hospital discharge reduce cardiovascular comorbidity in the first year after lung transplantation?
Category : Organ Transplants & Donation : Health & Medical
Donor-Derived Fungal Infections in Organ Transplant
Donor-derived fungal infections can be associated with serious complications in transplant recipients. How can they be curtailed?
Coccidioidomycosis in Liver Transplant in an Endemic Area
Coccidioidomycosis is a fungal infection that's endemic to the Southwestern US and may have an unwanted impact on liver transplant recipients.
Impact of Comorbidity on Individual Center Outcomes After Renal Transplantation
In this video blog, Ron Shapiro, MD, University of Pittsburgh, comments on a study that examined new ways of measuring outcomes at transplant centers.
Renal Allograft Loss After Early Antibody-Mediated Rejection
Do patients with subclinical rejection have higher rates of graft loss than AMR-free matched controls?
Bilateral Native Nephrectomy
The literature reports benefits of bilateral native nephrectomy for resistant hypertension and many report a high rate of success (around 80%), which is not the case in our experience.
The Use of daclizumab, tacrolimus & mycophenolate in Transplants
Newer potent drugs, tacrolimus (FK) and mycophenolate mofetil (MMF), in combination are being used as continuous immunosuppressive therapy and appear to be reducing or preventing acute rejection episodes, which may translate to better long-term graft and patient outcome.
Regulatory Failure and Deaths of Live Kidney Donors
Hemorrhagic deaths of living kidney donors from failure of vascular clips have continued due to postoperative Hem-o-lok clip failure -- since 2006.
Ask the Experts - Timing of Liver Transplantation in Patient With HCV?
I am taking care of a 40-year-old male with chronic hepatitis C virus (HCV) infection and cirrhosis, Child's class C. He has no history of encephalopathy and he is active in daily living apart from occasional fatigue. The rest of his organs are functioning normally. At this point, he is not a ca
Sirolimus in Combination With Tacrolimus
A retrospective study shows that tacrolimus plus sirolimus vs mycophenolate mofetil is associated with significantly worse renal allograft survival.
Future Direction of the Adult Heart Allocation System in US
Learn how OPTN/UNOS proposed changes to the heart allocation system can provide a framework for more effective and equitable allocation of organs.
Biliary Complications After Liver Transplantation
Get updated on the latest means of prevention and treatment of biliary complications, a major source of morbidity after liver transplantation.
Liver Transplantation in Patient With Acute Renal Failure?
Do you consider a 63-year-old patient with hepatocellular carcinoma, portal vein thrombosis, and acute renal failure a candidate for living-donor liver transplantation?
Ask the Experts - Positive CMV-Antigenemia With or Without PCR...
Some renal transplanted patients exhibit a positive cytomegalovirus (CMV)-antigenemia (more than 5 cells) with or without CMV-polymerase chain reaction (PCR) positive results and without any clinical signs of CMV infection.
Ask the Experts - Inguinal Hernia Repair in Patient With Liver Failure?
I have a patient with newly diagnosed, compensated liver failure (ascites controlled with diuretic therapy, Child's Class A) and an inguinal hernia that is symptomatic. What is the best type of repair in these patients?
Conference Report - New and Emerging Immunosuppressive Agents
Where is the focus of outcomes assessment in immunosuppression trials shifting?
Liver Transplantation
Chronic HCV infection is the leading cause of liver disease-related morbidity and mortality in the Western world.
Blood Transfusions in Patients Waiting for Kidney Transplantatio
Ask the Expert: What are the recommendations for giving blood transfusions to patients waiting for kidney transplantation?
Cardiff Transplant 2000
The half-life of the cadaver kidney allograft has steadily increased, but there is still a long way to go toward achieving an equivalent half-life of the living-related donor allograft.